$1.75 EPS Expected for CME Group Inc (NASDAQ:CME) This Quarter

Equities analysts predict that CME Group Inc (NASDAQ:CME) will post earnings of $1.75 per share for the current quarter, Zacks reports. Four analysts have issued estimates for CME Group’s earnings, with the lowest EPS estimate coming in at $1.67 and the highest estimate coming in at $1.78. CME Group reported earnings of $1.45 per share during the same quarter last year, which indicates a positive year over year growth rate of 20.7%. The firm is scheduled to issue its next earnings report before the market opens on Wednesday, October 30th.

According to Zacks, analysts expect that CME Group will report full year earnings of $6.83 per share for the current year, with EPS estimates ranging from $6.75 to $7.00. For the next year, analysts anticipate that the company will post earnings of $7.48 per share, with EPS estimates ranging from $7.07 to $8.06. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the firm posted $1.74 earnings per share. The business’s quarterly revenue was up 20.1% compared to the same quarter last year.

CME has been the topic of a number of recent research reports. ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Deutsche Bank raised their price objective on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Citigroup raised their price objective on CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. Finally, Berenberg Bank lowered CME Group from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $236.00 to $227.00 in a research note on Thursday, September 19th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $203.14.

NASDAQ CME traded down $2.79 during trading hours on Tuesday, hitting $200.46. 1,396,000 shares of the company traded hands, compared to its average volume of 1,100,877. The business’s 50-day moving average is $211.96 and its 200-day moving average is $199.69. CME Group has a twelve month low of $161.05 and a twelve month high of $224.91. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. The stock has a market capitalization of $72.78 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 4.28 and a beta of 0.20.

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total value of $7,005,250.00. Following the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Howard J. Siegel sold 5,000 shares of the firm’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $205.00, for a total value of $1,025,000.00. Following the completion of the sale, the director now directly owns 80,382 shares in the company, valued at approximately $16,478,310. The disclosure for this sale can be found here. In the last ninety days, insiders sold 57,126 shares of company stock worth $11,752,684. Company insiders own 1.20% of the company’s stock.

Several hedge funds have recently modified their holdings of CME. Nuveen Asset Management LLC boosted its holdings in shares of CME Group by 18,355.3% during the 2nd quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock valued at $628,631,000 after acquiring an additional 3,220,982 shares in the last quarter. Parnassus Investments CA acquired a new position in CME Group during the 2nd quarter worth about $544,292,000. Magellan Asset Management Ltd acquired a new position in CME Group during the 2nd quarter worth about $418,297,000. Fiera Capital Corp lifted its holdings in CME Group by 17.0% during the 2nd quarter. Fiera Capital Corp now owns 2,960,477 shares of the financial services provider’s stock worth $574,658,000 after buying an additional 429,235 shares during the period. Finally, Amundi Pioneer Asset Management Inc. lifted its holdings in CME Group by 30.4% during the 2nd quarter. Amundi Pioneer Asset Management Inc. now owns 1,664,500 shares of the financial services provider’s stock worth $323,097,000 after buying an additional 388,008 shares during the period. 84.90% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: What is the Bid-Ask Spread?

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.